Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Estimates of their viral inactivation market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
In 2017, the global Viral Inactivation market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global Viral Inactivation status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Viral Inactivation development in United States, Europe and China.
The key players covered in this study
Charles River Laboratories International
Rad Source Technologies
Viral Inactivated Plasma Systems
Wuxi Pharmatech (Cayman)
Market segment by Type, the product can be split into
Kits and Reagents
Viral Inactivation Systems and Accessories
Market segment by Application, split into
Blood and Blood Products
Cellular and Gene Therapy Products
Stem Cell Products
Tissue and Tissue Products
Vaccines and Therapeutics
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Viral Inactivation status, future forecast, growth opportunity, key market and key players.
To present the Viral Inactivation development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Viral Inactivation are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Viral Inactivation Market Size Growth Rate by Type (2013-2025)
1.4.2 Kits and Reagents
1.4.4 Viral Inactivation Systems and Accessories
1.5 Market by Application
1.5.1 Global Viral Inactivation Market Share by Application (2013-2025)
1.5.2 Blood and Blood Products
1.5.3 Cellular and Gene Therapy Products
1.5.4 Stem Cell Products
1.5.5 Tissue and Tissue Products
1.5.6 Vaccines and Therapeutics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Viral Inactivation Market Size
2.2 Viral Inactivation Growth Trends by Regions
2.2.1 Viral Inactivation Market Size by Regions (2013-2025)
2.2.2 Viral Inactivation Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Viral Inactivation Market Size by Manufacturers
3.1.1 Global Viral Inactivation Revenue by Manufacturers (2013-2018)
3.1.2 Global Viral Inactivation Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Viral Inactivation Market Concentration Ratio (CR5 and HHI)
3.2 Viral Inactivation Key Players Head office and Area Served